Atossa Therapeutics Inc
NASDAQ:ATOS

Watchlist Manager
Atossa Therapeutics Inc Logo
Atossa Therapeutics Inc
NASDAQ:ATOS
Watchlist
Price: 0.59 USD -5.07%
Market Cap: 76.2m USD

Intrinsic Value

The intrinsic value of one ATOS stock under the Base Case scenario is 4.68 USD. Compared to the current market price of 0.59 USD, Atossa Therapeutics Inc is Undervalued by 87%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATOS Intrinsic Value
4.68 USD
Undervaluation 87%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Atossa Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ATOS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ATOS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Atossa Therapeutics Inc.

Explain Valuation
Compare ATOS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATOS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Atossa Therapeutics Inc

Current Assets 55.7m
Cash & Short-Term Investments 51.8m
Other Current Assets 3.8m
Non-Current Assets 2.3m
Other Non-Current Assets 2.3m
Current Liabilities 8.2m
Accounts Payable 3.5m
Accrued Liabilities 3.1m
Other Current Liabilities 1.6m
Efficiency

Free Cash Flow Analysis
Atossa Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Atossa Therapeutics Inc

Revenue
0 USD
Operating Expenses
-32.9m USD
Operating Income
-32.9m USD
Other Expenses
2.7m USD
Net Income
-30.2m USD
Fundamental Scores

ATOS Profitability Score
Profitability Due Diligence

Atossa Therapeutics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Atossa Therapeutics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

ATOS Solvency Score
Solvency Due Diligence

Atossa Therapeutics Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
63/100
Solvency
Score

Atossa Therapeutics Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATOS Price Targets Summary
Atossa Therapeutics Inc

There are no price targets for ATOS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Atossa Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ATOS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ATOS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ATOS stock?

The intrinsic value of one ATOS stock under the Base Case scenario is 4.68 USD.

Is ATOS stock undervalued or overvalued?

Compared to the current market price of 0.59 USD, Atossa Therapeutics Inc is Undervalued by 87%.

Back to Top